References
- Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179(1):194–202.
- Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;11(1):18–25.
- Romero R, Chaiworapongsa T, Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003;133(5):1668S–1673S.
- Dong Y, Hou W, Wei J, et al. Chronic hypoxemia absent bacterial infection is one cause of the fetal inflammatory response syndrome (FIRS). Reprod Sci. 2009;16(7):650–656.
- Mittendorf R, Covert R, Montag AG, et al. Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates. J Perinat Med. 2005;33(5):428–434.
- Chiesa C, Pacifico L, Natale F, et al. Fetal and early neonatal interleukin-6 response. Cytokine. 2015;76(1):1–12.
- Zhang Q, Lu HY, Wang JX, et al. Relationship between placental inflammation and fetal inflammatory response syndrome and brain injury in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17(3):217–221.
- Dessardo NS, Dessardo S, Mustać E, et al. Chronic lung disease of prematurity and early childhood wheezing: is foetal inflammatory response syndrome to blame? Early Hum Dev. 2014;90(9):493–499.
- Hofer N, Kothari R, Morris N, et al. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol. 2013;209(6):542.e1–542.e11.
- Francis F, Bhat V, Mondal N, et al. Fetal inflammatory response syndrome (FIRS) and outcome of preterm neonates – a prospective analytical study. J Matern Fetal Neonatal Med. 2019;32(3):488–492.
- Ozalkaya E, Karatekin G, Topcuoğlu S, et al. Morbidity in preterm infants with fetal inflammatory response syndrome. Pediatr Int. 2016;58(9):850–854.
- Musilova I, Andrys C, Drahosova M, et al. Late preterm prelabor rupture of fetal membranes: fetal inflammatory response and neonatal outcome. Pediatr Res. 2018;83(3):630–637.
- Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34(1):5–12.
- Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007;50(3):652–683.
- Kent A, Lomas F, Hurrion E, et al. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. J Paediatr Child Health. 2005;41(4):186–190.
- Garcia-Flores V, Romero R, Miller D, et al. Inflammation-induced adverse pregnancy and neonatal outcomes can be improved by the immunomodulatory peptide Exendin-4. Front Immunol. 2018;9:1291.
- Dessardo NS, Mustać E, Dessardo S, et al. Chorioamnionitis and chronic lung disease of prematurity: a path analysis of causality. Am J Perinatol. 2012;29(2):133–140.
- Kunze M, Klar M, Morfeld CA, et al. Cytokines in noninvasively obtained amniotic fluid as predictors of fetal inflammatory response syndrome. Am J Obstet Gynecol. 2016;215(1):96.e1–96.e8.
- Lu HY, Zhang Q, Wang QX, et al. Contribution of histologic chorioamnionitis and fetal inflammatory response syndrome to increased risk of brain injury in infants with preterm premature rupture of membranes. Pediatr Neurol. 2016;61:94–98.e1.
- Özalkaya E, Karatekin G, Topçuoğlu S, et al. Neonatology oxidative status in preterm infants with premature preterm rupture of membranes and fetal inflammatuar response syndrome. Pediatr Neonatol. 2017;58(5):437–441.